ÂÜÀòÂÒÂ×

George Eldridge is the Senior Vice President and Chief Financial Officer at Proteon Therapeutics. George has over 25 years of experience as a Chief Financial Officer in the biotechnology industry.

George Eldridge began their career as a CFO at Therion Biologics in September 2002. George then became the CFO of Targanta Therapeutics in September 2006. In September 2009, they founded Biotech CFO Consulting, a consulting firm that provides financial and operational advice to biotech companies.

In February 2020, George Eldridge joined Sollis Therapeutics as their Chief Financial Officer. George was with the company for seven months before joining Lyndra Therapeutics as their Chief Financial Officer in October 2020. George served in this role for five months before returning to Proteon Therapeutics as their Senior Vice President and Chief Financial Officer in March 2021.

George Eldridge's educational career consists of an AB from Dartmouth College and an MBA from the University of Chicago.

George Eldridge reports to Timothy P. Noyes, President and Chief Executive Officer. George Eldridge works with John Najim - Vice President, Manufacturing and Process Development, Daniel P. Gottlieb - Vice President, Corporate Development, and Matthew Kowalsky - Vice President, Legal.